NCT06710262 - T-TAS® wS Method Comparison | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions

Antiplatelet TherapyHealthy DonorsVon Willebrand Disease (VWD)

Interventions

DIAGNOSTIC_TEST

T-TAS PL Assay

The T-TAS PL assay is a flow chamber assay for measuring primary hemostatic function

Trial Locations (2)

Sinai Hospital of Baltimore, Baltimore

University of Florida Health Jacksonville, Jacksonville

All Listed Sponsors

collaborator

ZACROS Corporation

UNKNOWN

lead

Hikari Dx, Inc.

OTHER